Steering Committee Meeting - 07/2009

From LipidomicsWiki

(Difference between revisions)
Jump to: navigation, search
Line 25: Line 25:
| 08:40 - 08:50  
| 08:40 - 08:50  
| Scientific Advisory Committee Prof. M. Wenk  
| Scientific Advisory Committee Prof. M. Wenk  
-
|  
+
| <br>
|-
|-
| 08:50 - 09:00  
| 08:50 - 09:00  
| Scientific Advisory Committee Prof. E. Dennis  
| Scientific Advisory Committee Prof. E. Dennis  
-
|  
+
| <br>
|-
|-
| 09:00 - 09:10  
| 09:00 - 09:10  
| Scientific Advisory Committee Prof. D. Brasaemle  
| Scientific Advisory Committee Prof. D. Brasaemle  
-
|  
+
| <br>
|-
|-
| 09:10 - 09:20  
| 09:10 - 09:20  
| Audit and Ethics Committee N. N. (no confirmation received)  
| Audit and Ethics Committee N. N. (no confirmation received)  
-
|  
+
| <br>
|-
|-
| 09:20 - 09:30  
| 09:20 - 09:30  
| Audit and Ethics Committee N. N. (no confirmation received)  
| Audit and Ethics Committee N. N. (no confirmation received)  
-
|  
+
| <br>
|-
|-
| colspan="3" | Work package and deliverable-orientated presentations
| colspan="3" | Work package and deliverable-orientated presentations
|-
|-
-
|  
+
| <br>
| WP 1 (Chair: Prof. G. Schmitz)  
| WP 1 (Chair: Prof. G. Schmitz)  
| Scientific management
| Scientific management
|-
|-
-
|  
+
| <br>
-
|
+
-
|
+
-
|-
+
-
|
+
-
|
+
-
|
+
-
|-
+
-
|
+
| WP 2, together with TF I - IV (Chair: Prof. C. Thiele)  
| WP 2, together with TF I - IV (Chair: Prof. C. Thiele)  
| Enabling technologies  
| Enabling technologies  
Line 65: Line 57:
|-
|-
-
|  
+
| <br>
| Dr. M. Grandl (P01)  
| Dr. M. Grandl (P01)  
| High content imaging of lipid droplets and phospho-lipidosis in differentiated and lipid loaded human macrophages
| High content imaging of lipid droplets and phospho-lipidosis in differentiated and lipid loaded human macrophages
|-
|-
-
|  
+
| <br>
| Dr. G. Liebisch (P01)  
| Dr. G. Liebisch (P01)  
| Analysis of glycerophosphoplipid species
| Analysis of glycerophosphoplipid species
|-
|-
-
|  
+
| <br>
| M. Scherer (P01)  
| M. Scherer (P01)  
| Analysis of sphingolipid species
| Analysis of sphingolipid species
|-
|-
-
|  
+
| <br>
| Dr. J. Hansen (P01)  
| Dr. J. Hansen (P01)  
| Identification of novel lipidomic targets during weight loss induced tissue remodelling using a planar protein array
| Identification of novel lipidomic targets during weight loss induced tissue remodelling using a planar protein array
|-
|-
-
|  
+
| <br>
| WP 3, together with TF V (Chair: Prof. C. Wolfrum)  
| WP 3, together with TF V (Chair: Prof. C. Wolfrum)  
| Mouse models of liver and adipose lipid droplet processing
| Mouse models of liver and adipose lipid droplet processing
|-
|-
-
|  
+
| <br>
| N. N. N. N:  
| N. N. N. N:  
| Rühl-Kooperation-Liver/LXR ATP10D and liver
| Rühl-Kooperation-Liver/LXR ATP10D and liver
|-
|-
-
|  
+
| <br>
| WP 4, together with TF VI + VII (Chair: Prof. M. Wakelam)  
| WP 4, together with TF VI + VII (Chair: Prof. M. Wakelam)  
| Dysregulation of liver and adipose lipid droplet processing in human diseases  
| Dysregulation of liver and adipose lipid droplet processing in human diseases  
Line 97: Line 89:
|-
|-
-
|  
+
| <br>
| Dr. V. Tarabin (P01)  
| Dr. V. Tarabin (P01)  
<br>  
<br>  
Line 103: Line 95:
| Transcriptional changes of genes associated with lipid metabolism during adipocyte differentiation
| Transcriptional changes of genes associated with lipid metabolism during adipocyte differentiation
|-
|-
-
|  
+
| <br>
| Dr. J. Ecker (P01)  
| Dr. J. Ecker (P01)  
| Metabolic changes of lipid metabolism during adipocyte differentiation
| Metabolic changes of lipid metabolism during adipocyte differentiation
|-
|-
-
|  
+
| <br>
| Dr. C. Hellerbrand / Dr. T. Weiss (P01)  
| Dr. C. Hellerbrand / Dr. T. Weiss (P01)  
<br>  
<br>  
Line 113: Line 105:
| Influence of palmitate and ω3/ ω6-fatty acids on human liver cells
| Influence of palmitate and ω3/ ω6-fatty acids on human liver cells
|-
|-
-
|  
+
| <br>
| colspan="2" | Coffee Break
| colspan="2" | Coffee Break
|-
|-
-
|  
+
| <br>
| WP 5 (Chair: Prof. Schmitz)  
| WP 5 (Chair: Prof. Schmitz)  
| Lipid droplets and lipid bodies in human macrophages and leukocytes  
| Lipid droplets and lipid bodies in human macrophages and leukocytes  
Line 124: Line 116:
|-
|-
-
|  
+
| <br>
| K. Rübsaamen (born Leidl) (P01)  
| K. Rübsaamen (born Leidl) (P01)  
| Lipidomic analysis of monocytes and granulocytes
| Lipidomic analysis of monocytes and granulocytes
|-
|-
-
|  
+
| <br>
| Dr. A. Sigrüner (P01)  
| Dr. A. Sigrüner (P01)  
| Lipidomics and transcriptomics of myeloid cell differentiation towards Monocyte/MФ and Granulocytes
| Lipidomics and transcriptomics of myeloid cell differentiation towards Monocyte/MФ and Granulocytes
|-
|-
-
|  
+
| <br>
| Dr. J. Ecker (P01)  
| Dr. J. Ecker (P01)  
| The role of SREBP-1c mediated induction of lipid metabolism for macrophage development
| The role of SREBP-1c mediated induction of lipid metabolism for macrophage development
|-
|-
-
|  
+
| <br>
| Dr. Margot Grandl (P01)  
| Dr. Margot Grandl (P01)  
| Transcriptomic and Lipidomic analysis of lipid loaded human macrophages with an induction of lipid droplets or lamellar bodies in the endolysosomal compartment.
| Transcriptomic and Lipidomic analysis of lipid loaded human macrophages with an induction of lipid droplets or lamellar bodies in the endolysosomal compartment.
|-
|-
-
|  
+
| <br>
| Dr. K. Leuthäuser-Jaschinski (P01)  
| Dr. K. Leuthäuser-Jaschinski (P01)  
| Transcriptomic analysis of lipid-laden human Niemann-Pick disease type C macrophages
| Transcriptomic analysis of lipid-laden human Niemann-Pick disease type C macrophages
|-
|-
-
|  
+
| <br>
| Dr. E. Orso/ Dr. K. Leuthäuser-Jaschinski (P01)  
| Dr. E. Orso/ Dr. K. Leuthäuser-Jaschinski (P01)  
| N/N
| N/N
|-
|-
-
|  
+
| <br>
| N/N  
| N/N  
| Influence of oral fat load on plasma and blood monocytes lipid species and transcriptomics
| Influence of oral fat load on plasma and blood monocytes lipid species and transcriptomics
|-
|-
-
|  
+
| <br>
| WP 6 (Chair: Prof. Sandhoff)  
| WP 6 (Chair: Prof. Sandhoff)  
| Cellular lipid entry pathways into Lipid Droplets and Lamellar Bodies
| Cellular lipid entry pathways into Lipid Droplets and Lamellar Bodies
|-
|-
-
|  
+
| bgcolor="#ffffcc" | <br>
-
|  
+
| bgcolor="#ffffcc" | Lunch
-
|  
+
|-
|-
-
|  
+
| <br>
-
|
+
-
|
+
-
|-
+
-
|
+
-
| colspan="2" | Lunch
+
-
|-
+
-
|
+
| WP 7, together with TF VIII (Chair: Dr. L. Martens)  
| WP 7, together with TF VIII (Chair: Dr. L. Martens)  
| Bioinformatics
| Bioinformatics
|-
|-
-
|  
+
| <br>
| Dr. P. Ugocsai (P01)  
| Dr. P. Ugocsai (P01)  
| Relation of sphingolipid species homeostasis and related genes polymorphism (GWA) in the EUROSPAN population study
| Relation of sphingolipid species homeostasis and related genes polymorphism (GWA) in the EUROSPAN population study
|-
|-
-
|  
+
| <br>
| J. Koopmann (P01)  
| J. Koopmann (P01)  
| Bioinformatic approaches for the combination of SNP data and lipidomic profiling in a genom-wide association study
| Bioinformatic approaches for the combination of SNP data and lipidomic profiling in a genom-wide association study
|-
|-
-
|  
+
| <br>
| WP 8, together with TF IX (Chair: Prof. A. Dembinska-Kieć)  
| WP 8, together with TF IX (Chair: Prof. A. Dembinska-Kieć)  
| Dissemination and training  
| Dissemination and training  
Line 187: Line 171:
|-
|-
-
|  
+
| <br>
| Coffee Break  
| Coffee Break  
-
|  
+
| <br>
|}
|}
Line 198: Line 182:
{| class="prettytable"
{| class="prettytable"
|-
|-
-
|  
+
| <br>
| colspan="2" | Tuesday, 14.07.2009
| colspan="2" | Tuesday, 14.07.2009
|-
|-
-
|  
+
| <br>
| colspan="2" | Advisory-report of the Scientific Advisory Committee and Audit and Ethics Committee  
| colspan="2" | Advisory-report of the Scientific Advisory Committee and Audit and Ethics Committee  
<br>  
<br>  
Line 208: Line 192:
|-
|-
-
|  
+
| <br>
| Scientific Advisory Committee  
| Scientific Advisory Committee  
Prof. M. Wenk  
Prof. M. Wenk  
-
|  
+
| <br>
|-
|-
-
|  
+
| <br>
-
| Scientific Advisory Committee  
+
| colspan="2" | Scientific Advisory Committee <br>
-
Prof. E. Dennis
+
-
 
+
-
|
+
|-
|-
-
|  
+
| <br>
-
| Scientific Advisory Committee  
+
| colspan="2" | Scientific Advisory Committee <br>
-
Prof. D. Brasaemle
+
-
 
+
-
|
+
|-
|-
-
|  
+
| <br>
| colspan="2" | Audit and Ethics Committee <br>
| colspan="2" | Audit and Ethics Committee <br>
|-
|-
-
|  
+
| <br>
| colspan="2" | Audit and Ethics Committee <br>
| colspan="2" | Audit and Ethics Committee <br>
|-
|-
-
|  
+
| <br>
| colspan="2" | Coffee break
| colspan="2" | Coffee break
|-
|-

Revision as of 16:11, 11 May 2009

Date

1st Annual Steering Committee Meeting Regensburg, 13th - 14th July 2009

Venue

University Hospital Regensburg Franz-Josef-Strauss-Allee 11D-93053 RegensburgGermany

 

Phone: +49-941-944-6203


Time Monday, 13.07.2009
08:30 - 08:40 Introduction / Welcome (Prof. G. Schmitz, Regensburg)
Presentations of the LipidomicNet Scientific Advisory Committee and Audit and Ethics Committee
08:40 - 08:50 Scientific Advisory Committee Prof. M. Wenk
08:50 - 09:00 Scientific Advisory Committee Prof. E. Dennis
09:00 - 09:10 Scientific Advisory Committee Prof. D. Brasaemle
09:10 - 09:20 Audit and Ethics Committee N. N. (no confirmation received)
09:20 - 09:30 Audit and Ethics Committee N. N. (no confirmation received)
Work package and deliverable-orientated presentations

WP 1 (Chair: Prof. G. Schmitz) Scientific management

WP 2, together with TF I - IV (Chair: Prof. C. Thiele) Enabling technologies




Dr. M. Grandl (P01) High content imaging of lipid droplets and phospho-lipidosis in differentiated and lipid loaded human macrophages

Dr. G. Liebisch (P01) Analysis of glycerophosphoplipid species

M. Scherer (P01) Analysis of sphingolipid species

Dr. J. Hansen (P01) Identification of novel lipidomic targets during weight loss induced tissue remodelling using a planar protein array

WP 3, together with TF V (Chair: Prof. C. Wolfrum) Mouse models of liver and adipose lipid droplet processing

N. N. N. N: Rühl-Kooperation-Liver/LXR ATP10D and liver

WP 4, together with TF VI + VII (Chair: Prof. M. Wakelam) Dysregulation of liver and adipose lipid droplet processing in human diseases




Dr. V. Tarabin (P01)


Transcriptional changes of genes associated with lipid metabolism during adipocyte differentiation

Dr. J. Ecker (P01) Metabolic changes of lipid metabolism during adipocyte differentiation

Dr. C. Hellerbrand / Dr. T. Weiss (P01)


Influence of palmitate and ω3/ ω6-fatty acids on human liver cells

Coffee Break

WP 5 (Chair: Prof. Schmitz) Lipid droplets and lipid bodies in human macrophages and leukocytes




K. Rübsaamen (born Leidl) (P01) Lipidomic analysis of monocytes and granulocytes

Dr. A. Sigrüner (P01) Lipidomics and transcriptomics of myeloid cell differentiation towards Monocyte/MФ and Granulocytes

Dr. J. Ecker (P01) The role of SREBP-1c mediated induction of lipid metabolism for macrophage development

Dr. Margot Grandl (P01) Transcriptomic and Lipidomic analysis of lipid loaded human macrophages with an induction of lipid droplets or lamellar bodies in the endolysosomal compartment.

Dr. K. Leuthäuser-Jaschinski (P01) Transcriptomic analysis of lipid-laden human Niemann-Pick disease type C macrophages

Dr. E. Orso/ Dr. K. Leuthäuser-Jaschinski (P01) N/N

N/N Influence of oral fat load on plasma and blood monocytes lipid species and transcriptomics

WP 6 (Chair: Prof. Sandhoff) Cellular lipid entry pathways into Lipid Droplets and Lamellar Bodies

Lunch

WP 7, together with TF VIII (Chair: Dr. L. Martens) Bioinformatics

Dr. P. Ugocsai (P01) Relation of sphingolipid species homeostasis and related genes polymorphism (GWA) in the EUROSPAN population study

J. Koopmann (P01) Bioinformatic approaches for the combination of SNP data and lipidomic profiling in a genom-wide association study

WP 8, together with TF IX (Chair: Prof. A. Dembinska-Kieć) Dissemination and training




Coffee Break




Tuesday, 14.07.2009

Advisory-report of the Scientific Advisory Committee and Audit and Ethics Committee




Scientific Advisory Committee

Prof. M. Wenk



Scientific Advisory Committee

Scientific Advisory Committee

Audit and Ethics Committee

Audit and Ethics Committee

Coffee break
13:00 End of meeting


Personal tools
Create a book